These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9111549)

  • 1. Transfusion-associated graft-versus-host disease in ataxia telangiectasia.
    Watson HG; McLaren KM; Todd A; Wallace WH
    Lancet; 1997 Jan; 349(9046):179. PubMed ID: 9111549
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chronic posttransfusion graft-vs-host disease in a patient with non-Hodgkin's lymphoma].
    García Gala JM; Ramírez Páyer A; Rayón C; Rodríguez Vicente P; Rosón C; Blanco C
    Sangre (Barc); 1993 Dec; 38(6):489-91. PubMed ID: 8171385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Transfusion related graft versus host disease. Indications for irradiated blood components].
    Muñiz-Díaz E; Martínez Valverde C; Sierra J; Madoz P
    Sangre (Barc); 1999 Dec; 44(6):483-8. PubMed ID: 10822764
    [No Abstract]   [Full Text] [Related]  

  • 4. Transfusion-associated graft-versus-host disease, monoclonal gammopathy and PCR.
    Blundell EL; Pamphilon DH; Anderson NA; Slade RR; Burton PA; Martin A; Ray T; Bradley BA; Lawler M; Humphries P
    Br J Haematol; 1992 Nov; 82(3):622-3. PubMed ID: 1486045
    [No Abstract]   [Full Text] [Related]  

  • 5. Atypical, nonfatal, transfusion-associated, acute graft-versus-host disease in a patient with Hodgkin's disease.
    Held JL; Druker BJ; Kohn SR; Byrnes W; Margolis RJ
    J Am Acad Dermatol; 1992 Feb; 26(2 Pt 1):261-2. PubMed ID: 1552066
    [No Abstract]   [Full Text] [Related]  

  • 6. Brief report: graft-versus-host disease associated with transfusion of blood from unrelated HLA-homozygous donors.
    Shivdasani RA; Haluska FG; Dock NL; Dover JS; Kineke EJ; Anderson KC
    N Engl J Med; 1993 Mar; 328(11):766-70. PubMed ID: 8437597
    [No Abstract]   [Full Text] [Related]  

  • 7. Residual immunological risks associated with red blood cell transfusion.
    Rouger P; Le Pennec PY
    Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):217-9. PubMed ID: 8337131
    [No Abstract]   [Full Text] [Related]  

  • 8. Broadening the spectrum of patient groups at risk for transfusion-associated GVHD: implications for universal irradiation of cellular blood components.
    Anderson K
    Transfusion; 2003 Dec; 43(12):1652-4. PubMed ID: 14641857
    [No Abstract]   [Full Text] [Related]  

  • 9. Analysis of 66 patients definitive with transfusion-associated graft-versus-host disease and the effect of universal irradiation of blood.
    Uchida S; Tadokoro K; Takahashi M; Yahagi H; Satake M; Juji T
    Transfus Med; 2013 Dec; 23(6):416-22. PubMed ID: 24274074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfusion safety in 2012: main messages from the SHOT Annual Report for 2012.
    Bolton-Maggs PH
    Transfus Med; 2013 Aug; 23(4):217-8. PubMed ID: 23865394
    [No Abstract]   [Full Text] [Related]  

  • 11. Guidelines on the use of irradiated blood components prepared by the British Committee for Standards in Haematology blood transfusion task force.
    Treleaven J; Gennery A; Marsh J; Norfolk D; Page L; Parker A; Saran F; Thurston J; Webb D
    Br J Haematol; 2011 Jan; 152(1):35-51. PubMed ID: 21083660
    [No Abstract]   [Full Text] [Related]  

  • 12. Preventing transfusion-associated graft-versus-host disease with blood component irradiation: indispensable guidance for a deadly disorder.
    Ní Loingsigh S; Flegel WA; Hendrickson JE; Tormey CA
    Br J Haematol; 2020 Dec; 191(5):653-657. PubMed ID: 32738068
    [No Abstract]   [Full Text] [Related]  

  • 13. Transfusion-associated graft-versus-host disease.
    Sunul H; Erguven N
    Transfus Apher Sci; 2013 Oct; 49(2):331-3. PubMed ID: 23890576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual reduction in the immunologic and infectious complications of transfusion by filtration/removal of leukocytes from donor blood soon after collection.
    Rawal BD; Davis RE; Busch MP; Vyas GN
    Transfus Med Rev; 1990 Oct; 4(4 Suppl 1):36-41. PubMed ID: 2134639
    [No Abstract]   [Full Text] [Related]  

  • 15. Transfusion of blood components to infants under four months: review and guidelines.
    O'Riordan JM; Fitzgerald J; Smith OP; Bonnar J; Gorman WA;
    Ir Med J; 2007 Jun; 100(6):suppl 1-24 following 496. PubMed ID: 17668683
    [No Abstract]   [Full Text] [Related]  

  • 16. Transfusion associated graft versus host disease.
    Tipu HN; Ahmed TA; Khalilullah ; Ahmed S; Satti T; Ahmed P
    J Pak Med Assoc; 2008 Mar; 58(3):143-5. PubMed ID: 18517122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfusion induced Graft versus host disease - Case report in a 2 year child.
    Naveen KN; Kabbin GM; Kulkarni V; Pai VV; Rao R
    Transfus Apher Sci; 2012 Aug; 47(1):17-9. PubMed ID: 22475546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatal transfusion-associated graft-versus-host disease caused by blood from an unrelated donor in an immunocompetent patient.
    Bell C
    Transfusion; 1993 Sep; 33(9):785-6. PubMed ID: 8212127
    [No Abstract]   [Full Text] [Related]  

  • 19. Transfusion associated graft versus host disease.
    Gupta A; Bansal D; Dass R; Das A
    Indian Pediatr; 2004 Dec; 41(12):1260-4. PubMed ID: 15623910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guidelines on gamma irradiation of blood components for the prevention of transfusion-associated graft-versus-host disease. BCSH Blood Transfusion Task Force.
    Transfus Med; 1996 Sep; 6(3):261-71. PubMed ID: 8885157
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.